Editorial Policies

Focus and Scope

The Marmara Pharmaceutical Journal is official scientific journal of Marmara University Faculty of Pharmacy. It is the continuation of the former "Journal of Pharmacy of University of Marmara" which was published between 1985 and 1997.
The Marmara Pharmaceutical Journal is published three times (January, May and September) a year. It is an open access, peer-reviewed journal for the publication of original papers, letters to the editor and comprehensive invited reviews in English or Turkish in all fields of the pharmaceutical sciences. It provides a medium for interdisciplinary papers of interest for many different specialists. In addition, it contains previous and forthcoming national and international scientific meetings and scientific and social activities in pharmaceutical fields.

 

Section Policies

Makaleler

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Standards and Procedures   Marmara Pharmaceutical Journal serves  to further academic discussions of topics, irrespective of their nature –  whether religious, gender-based, environmental, ethical, political or other  potentially or topically contentious subjects and adopts a neutral position on  issues.   Publication of an article in our academic  peer-reviewed journal involves many parties, the author, the journal editor, the  peer-reviewer; each have responsibilities to meet expected ethical standards at  all stages in their involvement from submission to publication of an  article.  

Marmara Pharmaceutical Journal is committed to  meeting and upholding standards of ethical behaviour at all stages of the  publication process. Marmara University Faculty of Pharmacy on behalf of which  it publishes shall ensure that good practice is maintained to the standards  outlined below.

Below is a summary of standards and  guidelines for best practices in order to meet our requirements.

 

Editors’ responsibilities

Contribution to Editorial Decision   The Editor is responsible  for deciding which of the papers submitted to the journal should be published.  The editor may confer with the members of the Editorial Board or reviewers in  making this decision.  

The editor may reject a manuscript  without additional opinions if it is deemed to be (a) inappropriate as to  subject matter or format; (b) of poor quality; or (c) of inadequate  significance. This decision, based primarily on the manuscript as submitted,  should take into account the editor’s assessment of the possible impact of  revisions by the author.

Editor should endeavor to  select reviewers who possess appropriate expertise and exercise sound judgment.  Editor then should ensure that the reviewers understand their responsibilities,  including those regarding confidentiality and the timely preparation of an  unbiased review.  The Editor should provide the corresponding author with a copy of the  reviewers’ comments regarding a manuscript. Before forwarding a reviewer’s  comments to an author, the editor may delete any inappropriately harsh language  or personal attacks included in the review. The need for these deletions should  be brought to the attention of the reviewer. Such language or attacks should  not influence the editor's decision regarding the manuscript, although it may  require the editor to seek input from an additional reviewer.

The editor  should correct errors in a manuscript if they are detected before publication  or publish corrections if they are detected afterward. All notices of  correction or retraction must be published prominently in the journal in which  the original report appeared and contain the full bibliographic reference to  the original article or abstract. It should also be listed in the contents page  and be prominently labeled (e.g., erratum, retraction, or apologia).

The editor is under no  obligation to reconsider a manuscript she/he has rejected. However, an editor  may offer the authors an opportunity to respond to criticisms and/or to prepare  a revised version. In this case, the editor should permit the authors a  reasonable but limited period of time in which to do so.

The editor should hold  authors to a high standard with regard to the citation of appropriate  literature, emphasizing the use of initial, peer-reviewed references whenever  possible. However, an editor should not encourage authors to cite the editors’  journal merely to enhance that journal’s reputation.

The editor should handle submissions for  sponsored supplements or special issues in the same way as other submissions,  so that articles are considered and accepted solely on their academic merit and  without commercial influence.

Confidentiality     The Editor and the members of the Editorial Board must  not disclose any information about a submitted paper to anyone other than the  authors of the paper, reviewers, potential reviewers, and the publisher, as  appropriate.

In the case where authors have a  conflict of interest, the editor may request that the authors include a  statement to this effect in the manuscript before it can be reviewed or  accepted for publication.     Disclosure and  conflicts of interest     Unpublished materials disclosed in a submitted paper  will not be used in the own research of the Editor or the members of the  Editorial Board without the express written consent of the author.   Standards of Objectivity     The editor should act in a balanced, objective  and fair way while carrying out their expected duties, without discrimination  on grounds of gender, sexual orientation, religious or political beliefs,  ethnic or geographical origin of the authors.

The editor should adopt and follow reasonable  procedures in the event of complaints of an ethical or conflict nature, in  accordance with the policies and procedures of the Society where  appropriate. To give authors a reasonable opportunity to respond to any  complaints. All complaints should be investigated no matter when the  original publication was approved. Documentation associated with any such  complaints should be retained.

Procedures for Dealing With Unethical Behaviour     Misconduct and unethical behaviour may be identified  and brought to the attention of the editor and publisher at any time, by  anyone. Whoever informs the editor or publisher of such conduct should provide  sufficient information and evidence in order for an investigation to be  initiated. All allegations should be taken seriously and treated in the  same way, until a successful decision or conclusion is reached.

The editor   should  gather evidences, while  avoiding spreading any allegations beyond those who need to know. Minor  misconduct might be dealt with without the need to consult more widely and the  author should be given the opportunity to respond to any allegations. The editor  should inform the author or reviewer where there appears to be a  misunderstanding or misapplication of acceptable standards as a warning to  future behaviour.

 

Serious misconduct or a case of  plagiarism comes to light after a paper is published; these cases might require that the employers  of the accused be notified. The editor should make the decision whether or  not to involve the employers, either by examining the available evidence itself  or by further consultation with a limited number of experts. The editor should  inform the author, the head of the author’s and reviewer’s department and  funding agency, abstracting & indexing services and the readership of the  publication concurrently with formal retraction or withdrawal of the  publication from the journal. The editor shoul lay a formal embargo on  contributions from an individual for a defined period.

 

Reviewers’ responsibilities

Contribution to Editorial  Decision and Promptness     The reviewer should contribute to the  decision-making process, and to assist in improving the quality of the  published paper by reviewing the manuscript objectively.

The reviewer receive an  invitation to review a manuscript at a time when circumstances preclude prompt  attention to it, the reviewer should decline the invitation in a timely manner.  The reviewer should submit his/her evaluation of the manuscript in a timely  manner.

The reviewer should  consider the quality and significance of the experimental and theoretical work,  the completeness of the description of methods and materials, the logical basis  of the interpretation of the results, and the exposition with due regard to the  maintenance of high standards of communication. Reviews should include  constructive suggestions for revision, including, if appropriate, indication of  where statements may require additional reference to the published literature.

The reviewers should  comment tactfully. Harsh language and personal attacks on the authors are  unacceptable; they also may call into question the validity of the reviewer's  comments.
    An individual who is asked  to review a manuscript and who feels inadequately qualified to judge that  manuscript should return the manuscript promptly without review and advise the  editor of  the circumstances.
    Confidentiality     The reviewer should maintain the  confidentiality of any information supplied by the editor or author. The  reviewer should  not retain or copy the  manuscript.

The Reviewer should not  use any information, arguments, or interpretations contained in a manuscript  under consideration to advance their research unless the information has been  made publicly available through another source, such as an abstract or a  presentation at a meeting, a stock offering, or a new article.
    Standards of Objectivity     The reviewer should not communicate with authors about a manuscript under  consideration. Likewise, authors should not initiate such a communication with  a reviewer but instead should communicate only with the editor. If an author  persists in attempting to communicate with a reviewer, that reviewer should  notify the editor.

Acknowledgement of Source  and Disclosure and Conflicts of Interest     The reviewer should be aware of any potential  conflicts of interest (financial, institutional, collaborative or other  relationships between the reviewer and author) and to alert the editor to  these, if necessary withdrawing their services for that manuscript.

 

Authors’ responsibilities

The  corresponding (submitting) author is solely responsible for communicating with  the journal and with managing communication between coauthors. Before  submission, the corresponding author ensures that all authors are included in  the author list, its order has been agreed by all authors, and that all authors  are aware that the paper was submitted. After acceptance, the proof is  sent to the corresponding author, who circulates it to all coauthors and deals  with the journal on their behalf; the journal will not necessarily correct  errors after publication if they result from errors that were present on a  proof that was not shown to coauthors before publication. The corresponding  author is responsible for the accuracy of all content in the proof, in  particular that names of coauthors are present and correctly spelled, and that  addresses and affiliations are current. The corresponding author is  welcome to suggest suitable independent reviewers when he/she submit his/her  manuscript, but the suggestion may not be followed by the journal.
    Reporting standards and Data Access and Retention     Authors should maintain accurate records of  data associated with their submitted manuscript, and to supply or provide  access to these data, on reasonable request. Where appropriate and where  allowed by employer, funding body and others who might have an interest, to deposit  data in a suitable repository or storage location, for sharing and further use  by others
    Originality and Plagiarism     Authors should confirm that all the work in the  submitted manuscript is original and to acknowledge and cite content reproduced  from other sources. The authors should obtain permission to reproduce any  content from other sources.
    Multiple, Redundant or Concurrent Publication     Authors should confirm/assert that the  manuscript as submitted is not under consideration or accepted for publication  elsewhere. Where portions of the content overlap with published or  submitted content, to acknowledge and cite those  sources. Additionally,  authors  should provide the editor with a copy of any submitted manuscript that might  contain overlapping or closely related content. 
    Hazards and Human or Animal Subjects     Authors should ensure that any studies  involving human or animal subjects conform to national, local and institutional  laws and requirements and confirm that approval has been sought and obtained  where appropriate. Authors should obtain express permission from human  subjects and respect their privacy.

 When reporting experiments on  human subjects, authors should indicate, in methods section whether the  procedures followed were in accordance with the ethical standards of the  responsible committee on human experimentation (institutional and national) and  with the Helsinki Declaration of 2008, http://www.wma.net/ en/30publications/ 10policies/b3/17c.pdf Manuscripts that report the results of experimental investigation with human  subjects must include a statement that informed consent was obtained after the  procedure(s) had been fully explained. In the case of children, authors are  asked to include information about whether the child's assent was obtained in  addition to that of the legal guardian. When reporting experiments on animals,  authors should indicate whether the institutional and national guides for the  care and use of laboratory animals were followed as in "Guide for the Care  and Use of Laboratory Animals" (www.nap.edu/ catalog/5140.html). The authors must mention  in the methods section of the manuscript that they had performed the study in  accordance with above-mentioned rules and, in the case of humans, emphasize  that they had received informed consent from the participants.
    Acknowledgement of Sources and Disclosure, Conflicts of Interest     Authors should declare any potential conflicts of interest (e.g. where  the author has a competing interest (real or apparent) that could be considered  or viewed as exerting an undue influence on his or her duties at any stage  during the publication process).
    Fundamental errors in published works

Authors should notify promptly the journal editor  or publisher if a significant error in their publication is identified. To  cooperate with the editor and publisher to publish an erratum, addendum,  corrigendum notice, or to retract the paper, where this is deemed necessary.  Authors should send the "copyright" and "authors forms" to the following address by mail.        

 

MARMARA PHARMACEUTICAL JOURNAL

The Marmara Pharmaceutical Journal is official scientific journal of Marmara University Faculty of Pharmacy. It is the continuation of the former "Journal of Pharmacy of University of Marmara" which was published between 1985 and 1997.
The Marmara Pharmaceutical Journal is published three times (January, May and September) a year. It is an open access, peer-reviewed journal for the publication of original papers, letters to the editor and comprehensive invited reviews in English or Turkish in all fields of the pharmaceutical sciences. It provides a medium for interdisciplinary papers of interest for many different specialists. In addition, it contains previous and forthcoming national and international scientific meetings and scientific and social activities in pharmaceutical fields.

 

Editor-in-Chief

İlkay Küçükgüzel

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

ikucukguzel@marmara.edu.tr

 

Associate Editor

Esra Tatar

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

etatar@marmara.edu.tr

 

Section Editors

Ali Demir Sezer

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

adsezer@marmara.edu.tr

 

Bedia Kaymakçıoğlu

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

bkaymakcioglu@marmara.edu.tr

 

Gülgün Tınaz

Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

gulgun.tinaz@marmara.edu.tr

 

Sevda Süzgeç Selçuk

Department of Pharmacognosy, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

sevdasuzgec@hotmail.com

 

Timuçin Uğurlu

Department of Pharmaceutical Technology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

tugurlu@marmara.edu.tr

 

Internet Editor

Erkan Rayaman

Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

erayaman@marmara.edu.tr

 

Copy Editor

Ayfer Beceren

Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

ayfertozan@hotmail.com

 

Biostatistics Editor

Alev Bakır

Department of Biostatistics, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, Turkey



 

Language Editor (English)

Işın Sayarı

Department of Translation and Interpreting (English), Faulty of Arts and Science, Marmara University, Istanbul, Turkey

isinsayari@marmara.edu.tr

 

Advisory Board Members

Ahmet Aydın

Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Yeditepe University, Istanbul, Turkey

 

Arzum Erdem

Department of Analytical Chemistry, Faculty of Pharmacy, Ege University, İzmir, Turkey

 

Ayşen Yarat

Department of Biochemistry, Faculty of Dentistry, Marmara University, Istanbul, Turkey

 

Azhar Hussain

Hamdard Institute of Pharmaceutical Sciences, Hamdard University,Pakistan

 

Azize Şener

Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Berrak Yeğen

Department of Physiology, School of Medicine, Marmara University, Istanbul, Turkey

 

Bezhan Chankvetadze

Institute of Physical and Analytical Chemistry, School of Exact and Natural Sciences, Tbilisi State University, Tbilisi, Georgia

 

Dharmarajan Sriram

Birla Institute of Technology & Science-Pilani, Department of Pharmacy, Hyderabad, India

 

Göksel Şener

Department of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Gülaçtı Topçu

Department of Pharmacognosy, Faculty of Pharmacy, Bezmialem Vakıf University Istanbul, Turkey

 

Gülay Melikoğlu

Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University Istanbul, Turkey

 

Hale Özcömert

Department of Pharmacy Management, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Hale Z. Toklu

Departments of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL, USA

 

Hartwig Andreas Steckel

Director R&D, Deva Holding A.Ş.

Department of Pharmaceutics and Biopharmaceutics, University of Kiel, Kiel, Germany

 

Jin-Ching Lee

Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan

 

Jülide Akbuğa

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Kübra Elçioğlu

Department of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Levent Kabasakal

Department of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Mesut Sancar

Department of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Nazlı Şencan

Department of Pharmacy Management, Faculty of Pharmacy, Yeditepe University, Istanbul, Turkey

 

Nilgün Karalı

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, İstanbul University, Istanbul, Turkey

 

Oya Kerimoğlu Sipahigil

Department of Pharmaceutical Technology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Perumal Yogeeswari

Birla Institute of Technology & Science-Pilani, Department of Pharmacy, Hyderabad, India

 

Refiye Yanardağ

Department of Chemistry, Faculty of Engineering, Istanbul University, Istanbul, Turkey

 

Rıdvan Nepravishta

Department of Chemical Sciences and Technologies, University of Rome “Tor Vergata”, Rome, Italy

 

Semra Şardaş

Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Sibel Özkan

Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey

Ş.Güniz Küçükgüzel

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

 

Tarık Satić

Pharmaceutical Society of Federation of Bosnia and Herzegovina, Bosnia and Herzegovina

 

Tuğba Tunalı Akbay

Department of Biochemistry, Faculty of Dentistry, Marmara University, Istanbul, Turkey

 

Vinayak Shenoy

Department of Pharmacodynamics, College of Medicine, University of Florida, Gainesville, FL, USA

 

Wolfgang Sippl

Institute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle / Saale, Germany

 

Yalçın Özkan

Department of Pharmaceutical Sciences, University of Health Sciences, Gülhane Complex, 06018 Etlik, Ankara, Turkey



ISSN: 1309-0801